本页面由Tiger Trade Technology Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

65.75
+0.40000.61%
成交量:177.89万
成交额:1.17亿
市值:128.74亿
市盈率:-18.42
高:66.42
开:65.35
低:65.20
收:65.35
52周最高:93.42
52周最低:52.75
股本:1.96亿
流通股本:1.67亿
量比:0.68
换手率:1.07%
股息:- -
股息率:- -
每股收益(TTM):-3.5686
每股收益(LYR):-3.7850
净资产收益率:-1789.67%
总资产收益率:-26.00%
市净率:-5.12
市盈率(LYR):-17.37

数据加载中...

2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/25

重要事件披露

Form 8-K - Current report
2024/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/06

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/17

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/11

重要事件披露

Form 8-K - Current report
2024/08/21

重要事件披露

Form 8-K - Current report
2024/08/20

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/01

重要事件披露

Form 8-K - Current report